During his visit to Rogers Memorial, Dr. Martin H. Teicher presented on the development of biobehavioral markers for the assessment of ADHD and the neurobiology of childhood abuse.

Drs. Bradley Riemann, Dave Moulthrop, Kambiz Pahlavan and Martin Teicher pose during Teicher’s visit to Rogers Memorial on May 20.
Dr. Teicher has been Director of the Developmental Biopsychiatry Research Program at McLean Hospital since 1988. Dr. Teicher has served an Associate Professor of Psychiatry at Harvard Medical School and Chief of the Developmental Psychopharmacology Laboratory at the Mailman Research Center since 1990. He is a member of the Editorial Board of the Journal of Child and Adolescent Psychopharmacology, Current Pediatric Reviews, and Current Psychosomatic Medicine. He is member of the Scientific Advisory Council of the Juvenile Bipolar Research Foundation, and been part of Harvard University's Brain Development Working Group. He has served on or chaired numerous review committees for the National Institute of Health, published more than 150 articles, and has received numerous honors.
A researcher and clinician with an unusual background in mathematics and technology, Dr. Teicher has succeeded in taking problems from the bedside to the laboratory bench and has then translated his findings back through clinical research trials to develop new tools for clinicians. His capacity to attack problems from multiple levels in multiple domains has enabled him to pioneer new areas, including depression in children, adults and geriatric patients, ADHD, post-traumatic stress disorder, and Alzheimer’s disease.